ID   ALG11_HUMAN             Reviewed;         492 AA.
AC   Q2TAA5; A5PLP3; B4DKW9; Q5TAN9; Q6DKI6; Q96FI7;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   10-MAY-2017, entry version 104.
DE   RecName: Full=GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase;
DE            EC=2.4.1.131;
DE   AltName: Full=Asparagine-linked glycosylation protein 11 homolog;
DE   AltName: Full=Glycolipid 2-alpha-mannosyltransferase;
GN   Name=ALG11; Synonyms=GT8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, VARIANT CDG1P
RP   SER-86, CHARACTERIZATION OF VARIANT CDG1P SER-86, AND MUTAGENESIS OF
RP   LEU-86.
RX   PubMed=20080937; DOI=10.1093/hmg/ddq016;
RA   Rind N., Schmeiser V., Thiel C., Absmanner B., Lubbehusen J.,
RA   Hocks J., Apeshiotis N., Wilichowski E., Lehle L., Korner C.;
RT   "A severe human metabolic disease caused by deficiency of the
RT   endoplasmatic mannosyltransferase hALG11 leads to congenital disorder
RT   of glycosylation-Ip.";
RL   Hum. Mol. Genet. 19:1413-1424(2010).
RN   [5]
RP   VARIANTS CDG1P SER-279; PRO-318; SER-381 AND LYS-398.
RX   PubMed=22213132; DOI=10.1002/humu.22019;
RA   Thiel C., Rind N., Popovici D., Hoffmann G.F., Hanson K., Conway R.L.,
RA   Adamski C.R., Butler E., Scanlon R., Lambert M., Apeshiotis N.,
RA   Thiels C., Matthijs G., Korner C.;
RT   "Improved diagnostics lead to identification of three new patients
RT   with congenital disorder of glycosylation-Ip.";
RL   Hum. Mutat. 33:485-487(2012).
CC   -!- FUNCTION: Mannosyltransferase involved in the last steps of the
CC       synthesis of Man5GlcNAc(2)-PP-dolichol core oligosaccharide on the
CC       cytoplasmic face of the endoplasmic reticulum. Catalyzes the
CC       addition of the 4th and 5th mannose residues to the dolichol-
CC       linked oligosaccharide chain. {ECO:0000269|PubMed:20080937}.
CC   -!- CATALYTIC ACTIVITY: 2 GDP-alpha-D-mannose + D-Man-alpha-(1->3)-(D-
CC       Man-alpha-(1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-
CC       diphosphodolichol = 2 GDP + D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-
CC       D-Man-alpha-(1->3)-(D-Man-alpha-(1->6))-D-Man-beta-(1->4)-D-
CC       GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol.
CC       {ECO:0000269|PubMed:20080937}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:20080937}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:20080937}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:20080937}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1P (CDG1P)
CC       [MIM:613661]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:20080937,
CC       ECO:0000269|PubMed:22213132}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase group 1 family.
CC       Glycosyltransferase 4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI11023.1; Type=Frameshift; Positions=16; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296747; BAG59331.1; -; mRNA.
DR   EMBL; AL139082; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC073862; AAH73862.1; -; mRNA.
DR   EMBL; BC010857; AAH10857.3; -; mRNA.
DR   EMBL; BC111022; AAI11023.1; ALT_SEQ; mRNA.
DR   EMBL; BC142998; AAI42999.1; -; mRNA.
DR   CCDS; CCDS31977.1; -.
DR   RefSeq; NP_001004127.2; NM_001004127.2.
DR   UniGene; Hs.512963; -.
DR   UniGene; Hs.732220; -.
DR   ProteinModelPortal; Q2TAA5; -.
DR   BioGrid; 136328; 8.
DR   STRING; 9606.ENSP00000430236; -.
DR   CAZy; GT4; Glycosyltransferase Family 4.
DR   iPTMnet; Q2TAA5; -.
DR   PhosphoSitePlus; Q2TAA5; -.
DR   BioMuta; ALG11; -.
DR   DMDM; 156631015; -.
DR   EPD; Q2TAA5; -.
DR   MaxQB; Q2TAA5; -.
DR   PaxDb; Q2TAA5; -.
DR   PeptideAtlas; Q2TAA5; -.
DR   PRIDE; Q2TAA5; -.
DR   DNASU; 440138; -.
DR   Ensembl; ENST00000521508; ENSP00000430236; ENSG00000253710.
DR   GeneID; 440138; -.
DR   KEGG; hsa:440138; -.
DR   UCSC; uc001vga.4; human.
DR   CTD; 440138; -.
DR   DisGeNET; 440138; -.
DR   GeneCards; ALG11; -.
DR   GeneReviews; ALG11; -.
DR   H-InvDB; HIX0011337; -.
DR   HGNC; HGNC:32456; ALG11.
DR   HPA; HPA047214; -.
DR   MalaCards; ALG11; -.
DR   MIM; 613661; phenotype.
DR   MIM; 613666; gene.
DR   neXtProt; NX_Q2TAA5; -.
DR   OpenTargets; ENSG00000253710; -.
DR   Orphanet; 280071; ALG11-CDG.
DR   eggNOG; KOG1387; Eukaryota.
DR   eggNOG; COG0438; LUCA.
DR   GeneTree; ENSGT00550000075118; -.
DR   HOGENOM; HOG000209670; -.
DR   HOVERGEN; HBG057178; -.
DR   InParanoid; Q2TAA5; -.
DR   KO; K03844; -.
DR   OMA; GTVILAH; -.
DR   OrthoDB; EOG091G0803; -.
DR   PhylomeDB; Q2TAA5; -.
DR   TreeFam; TF313056; -.
DR   BRENDA; 2.4.1.131; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   ChiTaRS; ALG11; human.
DR   GeneWiki; ALG11; -.
DR   GenomeRNAi; 440138; -.
DR   PRO; PR:Q2TAA5; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000253710; -.
DR   CleanEx; HS_ALG11; -.
DR   ExpressionAtlas; Q2TAA5; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0004377; F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006490; P:oligosaccharide-lipid intermediate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0033577; P:protein glycosylation in endoplasmic reticulum; IBA:GO_Central.
DR   InterPro; IPR031814; ALG11_N.
DR   InterPro; IPR001296; Glyco_trans_1.
DR   Pfam; PF15924; ALG11_N; 1.
DR   Pfam; PF00534; Glycos_transf_1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital disorder of glycosylation;
KW   Disease mutation; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Membrane; Polymorphism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    492       GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-
FT                                mannosyltransferase.
FT                                /FTId=PRO_0000295616.
FT   TRANSMEM     20     40       Helical. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical. {ECO:0000255}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    273    273       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      86     86       L -> S (in CDG1P; does not affect
FT                                subcellular localization; results in the
FT                                accumulation of under-glycosylated
FT                                proteins; dbSNP:rs267606652).
FT                                {ECO:0000269|PubMed:20080937}.
FT                                /FTId=VAR_064908.
FT   VARIANT     108    108       N -> S (in dbSNP:rs17480245).
FT                                /FTId=VAR_055902.
FT   VARIANT     279    279       Y -> S (in CDG1P; dbSNP:rs387907181).
FT                                {ECO:0000269|PubMed:22213132}.
FT                                /FTId=VAR_068070.
FT   VARIANT     318    318       Q -> P (in CDG1P; dbSNP:rs387907184).
FT                                {ECO:0000269|PubMed:22213132}.
FT                                /FTId=VAR_068071.
FT   VARIANT     381    381       L -> S (in CDG1P; dbSNP:rs387907182).
FT                                {ECO:0000269|PubMed:22213132}.
FT                                /FTId=VAR_068072.
FT   VARIANT     398    398       E -> K (in CDG1P; dbSNP:rs387907183).
FT                                {ECO:0000269|PubMed:22213132}.
FT                                /FTId=VAR_068073.
FT   MUTAGEN      86     86       L->A: Does not affect function.
FT                                {ECO:0000269|PubMed:20080937}.
FT   MUTAGEN      86     86       L->P: Loss of function.
FT                                {ECO:0000269|PubMed:20080937}.
FT   CONFLICT     96     96       A -> V (in Ref. 3; AAI42999).
FT                                {ECO:0000305}.
SQ   SEQUENCE   492 AA;  55651 MW;  1B3B0789030777FC CRC64;
     MAAGERSWCL CKLLRFFYSL FFPGLIVCGT LCVCLVIVLW GIRLLLQRKK KLVSTSKNGK
     NQMVIAFFHP YCNAGGGGER VLWCALRALQ KKYPEAVYVV YTGDVNVNGQ QILEGAFRRF
     NIRLIHPVQF VFLRKRYLVE DSLYPHFTLL GQSLGSIFLG WEALMQCVPD VYIDSMGYAF
     TLPLFKYIGG CQVGSYVHYP TISTDMLSVV KNQNIGFNNA AFITRNPFLS KVKLIYYYLF
     AFIYGLVGSC SDVVMVNSSW TLNHILSLWK VGNCTNIVYP PCDVQTFLDI PLHEKKMTPG
     HLLVSVGQFR PEKNHPLQIR AFAKLLNKKM VESPPSLKLV LIGGCRNKDD ELRVNQLRRL
     SEDLGVQEYV EFKINIPFDE LKNYLSEATI GLHTMWNEHF GIGVVECMAA GTIILAHNSG
     GPKLDIVVPH EGDITGFLAE SEEDYAETIA HILSMSAEKR LQIRKSARAS VSRFSDQEFE
     VTFLSSVEKL FK
//
